Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.